Advertisement

Clinical Reviews in Allergy & Immunology

, Volume 15, Issue 3, pp 243–269 | Cite as

Marijuana

Respiratory tract effects
  • Brent E. Van Hoozen
  • Carroll E. Cross
Pulmonary Complications of Recreational Drug Usage

Summary and Conclusions

Daily marijuana smoking has been clearly shown to have adverse effects on pulmonary function and produce respiratory symptomatology (cough, wheeze, and sputum production) similar to that of tobacco smokers. Based on the tobacco experience, decrements in pulmonary function may be predictive of the future development of chronic obstructive pulmonary disease (COPD). However, in the absence of α-l-antitrypsin deficiency, the habitual marijuana-only smoker would likely have to smoke 4–5 joints per day for a span of at least 30 yr in order to develop overt manifestations of COPD.

Keywords

Chronic Obstructive Pulmonary Disease Tobacco Smoke Clinical Review Respiratory Effect Immunology Volume 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Preliminary estimates from the 1995 national household survey on drug abuse. (1995), U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD, pp. 16, 59, 61, and 70.Google Scholar
  2. 2.
    Maykut, M. O. (1985),Prog. Neuropsychopharmacol. Biol. Psychiatry 9, 209–238.PubMedCrossRefGoogle Scholar
  3. 3.
    Tashkin, D. P. (moderator) (1978),Ann. Intern., Med. 89, 539–549.Google Scholar
  4. 4.
    Nahas, G. and Latour, C. (1992),Med. J. Aust. 156, 495–497.PubMedGoogle Scholar
  5. 5.
    Kephalas, T. A., Kiburis, J., Michael, C. M., Miras, C. J., and Papadakis, D. P. (1976), inMarihuana: Chemistry, Biochemistry and Cellular Effects, Nahas, G. G., ed., Springer-Verlag, New York, pp. 39–49.Google Scholar
  6. 6.
    Huber, G. L., First, M. W., and Grubner, O. (1991),Pharmacol. Biochem. Behav. 40, 629–636.PubMedCrossRefGoogle Scholar
  7. 7.
    Tashkin, D. P., Gliederer, F., Rose, J., Chang, P., Hui, K. K., Yu, J. L., and Wu, T. C. (1991),Pharmacol. Biochem. Behav. 40, 657–661.PubMedCrossRefGoogle Scholar
  8. 8.
    Wu, T. C., Tashkin, D. P., Djahed, B., and Rose, J. E. (1988),N. Engl. J. Med. 318, 347–351.PubMedCrossRefGoogle Scholar
  9. 9.
    Tashkin, D. P., Gliederer, F., Rose, J., Chang, P., Hui, K. K., Yu, J. L., and Wu, T. C. (1991),Pharmacol. Biochem. Behav.,40, 651–656.PubMedCrossRefGoogle Scholar
  10. 10.
    Agurell, S., Lindgren, J. E., and Ohlsson, A. (1979) inAdvances in the Biosciences: Marihuana: Biological Effects; Analysis, Metabolsim, Cellular Response, Reproduction and Brain, Nahas, G. G. and Paton, W. D. M., eds., Pergamon, Oxford, pp. 3–13.Google Scholar
  11. 11.
    Hollister, L. E. (1986),Pharmacol. Rev. 38, 1–20.PubMedGoogle Scholar
  12. 12.
    Cone, E. J. and Huestis, M. A. (1993),Ther. Drug Monit. 15, 527–532.PubMedCrossRefGoogle Scholar
  13. 13.
    Nahas, G., Leger, C., Tocque, B., and Hoellinger, H. (1981),J. Clin. Pharmacol. 21, 208S-214S.PubMedGoogle Scholar
  14. 14.
    Lemberger, L., McMahon, R., and Archer, R. (1976), inPharmacology of Marihuana. Braude, M. C. and Szara, S., eds., Raven, New York, pp. 125–135.Google Scholar
  15. 15.
    Crawley, J. N., Corwin, R. L., Robinson, J. K., Felder, C. C., Devane, W. A., and Axelrod, J. (1993),Pharmacol. Biochem. Behav. 46, 967–972.PubMedCrossRefGoogle Scholar
  16. 16.
    Devane, W. A., Dysarz, F. A., III, Johnson, M. R., Melvin, L. S., and Howlett, A. C. (1988),Mol. Pharmacol. 34, 605–613.PubMedGoogle Scholar
  17. 17.
    Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., and Rice, K. C. (1991),J. Neurosci 11, 563–583.PubMedGoogle Scholar
  18. 18.
    Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., and Rice, K. C. (1990),Proc. Natl. Acad. Sci. USA 87, 1932–1936.PubMedCrossRefGoogle Scholar
  19. 19.
    Mailleux, P. and Vanderhaeghen, J. J. (1992),Neurosci. Lett. 147, 179–181.PubMedCrossRefGoogle Scholar
  20. 20.
    Matsuda, L. A., Bonner, T. I., and Lolait, S. J. (1993),J. Comp. Neurol. 327, 535–550.PubMedCrossRefGoogle Scholar
  21. 21.
    Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., and Matsuda, L. A. (1992),Mol. Pharmacol. 42, 838–845.PubMedGoogle Scholar
  22. 22.
    Howlett, A. C. (1984),Life Sci.,35, 1803–1810.PubMedCrossRefGoogle Scholar
  23. 23.
    Mackie, K. and Hille, B. (1992),Proc. Natl. Acad. Sci. USA 89, 3825–3829.PubMedCrossRefGoogle Scholar
  24. 24.
    Caulfield, M. P. and Brown, D. A. (1992),Br. J. Pharmacol.,106, 231, 232.PubMedGoogle Scholar
  25. 25.
    Mackie, K., Devane, W. A., and Hille, B. (1993),Mol. Pharmacol. 44, 498–503.PubMedGoogle Scholar
  26. 26.
    Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R. (1995),J. Neurosci. 15 6552–6561.PubMedGoogle Scholar
  27. 27.
    Childers, S. R. and Deadwyler, S. A. (1996),Biochem. Pharmacol. 52, 819–827.PubMedCrossRefGoogle Scholar
  28. 28.
    Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., and Mitchell, R. L. (1995),Mol. Pharmacol. 48, 443–450.PubMedGoogle Scholar
  29. 29.
    Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B. Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J. C., and Le Fur G. (1994),FEBS Lett. 350, 240–244.PubMedCrossRefGoogle Scholar
  30. 30.
    Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., Le Fur, G., and Casellas, P. (1993),Eur. J. Biochem. 214, 173–180.PubMedCrossRefGoogle Scholar
  31. 31.
    Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., and Schatz, A. R. (1992),Mol. Pharmacol. 42, 736–742.PubMedGoogle Scholar
  32. 32.
    Rinaldi-Carmona, M., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Brelière, J. C., Soubriè, P., and Le Fur, G. (1996),Life Sci. 58, 1239–1247.PubMedCrossRefGoogle Scholar
  33. 33.
    Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992),Science 258, 1946–1949.PubMedCrossRefGoogle Scholar
  34. 34.
    Deutsch, D. G. and Chin, S. A. (1993),Biochem. Pharmacol. 46, 791–796.PubMedCrossRefGoogle Scholar
  35. 35.
    Devane, W. A. and Axelrod, J. (1994),Proc. Natl. Acad. Sci. USA 91, 6698–6701.PubMedCrossRefGoogle Scholar
  36. 36.
    Kruszka, K. K. and Gross, R. W. (1994),J. Biol. Chem. 269, 14,345–14,348.Google Scholar
  37. 37.
    Bornheim, L. M., Kim, K. Y., Chen, B., and Correia, M. A. (1993),Biochem. Biophys. Res. Commun. 197, 740–746.PubMedCrossRefGoogle Scholar
  38. 38.
    Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., and Piomelli, D. (1994),Nature 372, 686–691.PubMedCrossRefGoogle Scholar
  39. 39.
    Fride, E. (1995),Brain Res. 697, 83–90.PubMedCrossRefGoogle Scholar
  40. 40.
    Fride, E. and Mechoulam, R. (1993),Eur. J. Pharmacol. 231, 313, 314.PubMedCrossRefGoogle Scholar
  41. 41.
    Mechoulam, R. and Fride, E. (1995), inCannabinoid Receptors, Pertwee, R. G., ed., Academic, London, pp. 233–258.Google Scholar
  42. 42.
    Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., and Martin, B. R. (1993),J. Pharmacol. Exp. Ther. 265, 218–226.PubMedGoogle Scholar
  43. 43.
    Compton, D. R., Aceto, M. D., Lowe, J., and Martin, B. R. (1996),J. Pharmacol. Exp. Ther. 277, 586–594.PubMedGoogle Scholar
  44. 44.
    Thomas, B. F., Adams, I. B., Mascarella, S. W., Martin, B. R., and Razdan, R. K. (1996),J. Med. Chem. 39, 471–479.PubMedCrossRefGoogle Scholar
  45. 45.
    Pope, H. G., Jr. and Yurgelun-Todd, D. (1996),JAMA 275, 521–527.PubMedCrossRefGoogle Scholar
  46. 46.
    Page, J. B., Fletcher, J., and True, W. R. (1988),J. Psychoactive Drugs 20 57–65.PubMedGoogle Scholar
  47. 47.
    Varma, V. K., Malhotra, A. K., Dang, R., Das, K., and Nehra, R. (1988),Drug Alcohol Depend. 21, 147–152.PubMedCrossRefGoogle Scholar
  48. 48.
    Schwartz, R. H., Gruenewald, P. J., Klitzner, M., and Fedio, P. (1989),Am. J. Dis. Child. 143, 1214–1219.PubMedGoogle Scholar
  49. 49.
    Leirer, V. O., Yesavage, J. A., and Morrow, D. G. (1991),Aviat. Space Environ. Med. 62, 221–227.PubMedGoogle Scholar
  50. 50.
    Scheier, L. M. and Botvin, G. J. (1996) (letter),JAMA 275, 1547.PubMedCrossRefGoogle Scholar
  51. 51.
    Block, R. I. (1996) (editorial)JAMA 275, 560, 561.PubMedCrossRefGoogle Scholar
  52. 52.
    Pope, H. G., Jr., Gruber, A. J., and Yurgelun-Todd, D. (1995),Drug Alcohol Depend. 38, 25–34.PubMedCrossRefGoogle Scholar
  53. 53.
    Yesavage, J. A., Leirer, V. O., Denari, M., and Hollister, L. E. (1985),Am. J. Psychiatry 142, 1325–1329.PubMedGoogle Scholar
  54. 54.
    Leirer, V. O., Yesavage, J. A., and Morrow, D. G. (1989),Aviat. Space Environ. Med. 60, 1145–1152.PubMedGoogle Scholar
  55. 55.
    Satz, P., Fletcher, J. M., and Sutker, L. S. (1976),Ann. N. Y. Acad. Sci. 282, 266–306.PubMedCrossRefGoogle Scholar
  56. 56.
    Tashkin, D. P., Shapiro, B. J., and Frank, I. M. (1974),Am. Rev. Respir. Dis. 109, 420–428.PubMedGoogle Scholar
  57. 57.
    Tashkin, D. P., Shapiro, B. J., and Frank, I. M. (1973),N. Engl. J. Med. 289, 336–341.PubMedCrossRefGoogle Scholar
  58. 58.
    Shapiro, B. J. and Tashkin, D. P. (1976), inThe Pharmacology of Marijuana, Braude, M. C. and Szara, S., eds., Raven, New York, pp. 277–289.Google Scholar
  59. 59.
    Tashkin, D. P., Reiss, S., Shapiro, B. J., Calvarese, B., Olsen, J. L., and Lodge, J. W. (1977),Am. Rev. Respir. Dis. 115, 57–65.PubMedGoogle Scholar
  60. 60.
    Williams, S. J., Hartley, J. P., and Graham, J. D. (1976),Thorax,31, 720–723.PubMedGoogle Scholar
  61. 61.
    Tashkin, D. P., Shapiro, B. J., Lee, Y. E., and Harper, C. E. (1976),N. Engl. J. Med. 294, 125–129.PubMedCrossRefGoogle Scholar
  62. 62.
    Wu, H. D., Wright, R. S., Sassoon, C. S. H., and Tashkin, D. P. (1992),Am. Rev. Respir. Dis. 146, 716–721.PubMedGoogle Scholar
  63. 63.
    Szeto, H. H., Wu, D. L., Cheng, Y., Cheng, P. Y., and Decena, J. A. (1992),Pharmacol. Biochem. Behav. 43, 1227–1231.PubMedCrossRefGoogle Scholar
  64. 64.
    Starr, K. and Renneker, M. (1994),J. Fam. Pract. 39, 359–363.PubMedGoogle Scholar
  65. 65.
    Gong, H., Jr., Fligiel, S., Tashkin, D. P., and Barbers, R. G. (1987),Am. Rev. Respir. Dis. 136, 142–149.PubMedGoogle Scholar
  66. 66.
    Fligiel, S. E. G., Beals, T. F., Tashkin, D. P., M. G. Scallet, A. C., Ali, S. F., Bailey, J. R., and Slikker, W., Jr. (1991),Pharmacol. Biochem. Behav. 40, 637–642.PubMedCrossRefGoogle Scholar
  67. 67.
    Fleischman, R. W., Baker, J. R., and Rosenkrantz, H. (1979),Toxicol. Appl. Pharmacol. 47, 557–566.PubMedCrossRefGoogle Scholar
  68. 68.
    Fleischman, R. W., Hayden, D. W., Braude, M. C., and Rosenkrantz, H. (1975),Toxicol. Appl. Pharmacol. 34, 467–478.PubMedCrossRefGoogle Scholar
  69. 69.
    Rosenkrantz, H. and Fleischman, R. W. (1979), inMarijuana: Biological Effects, Nahas, G. G. and Paton, W. D. H., eds., Oxford, England, Pergamon, pp. 279–299.Google Scholar
  70. 70.
    Roy, P. E., Magnan-Lapointe, F., Huy, N. D., and Boutet, M. (1976),Res. Commun. Chem. Pathol. Pharmacol. 14, 305–317.PubMedGoogle Scholar
  71. 71.
    Fligiel, S. E. G., Beals, T. F., Venkat, H., Stuth, S., Gong, H., Jr., and Tashkin, D. P. (1988), inMarijuana: An international research report. Proceedings of the Melbourne symposium on cannabis, Chesher, G., Consroe, P., Musty, R., eds., Monograph series no. 7., Australian Government Publishing Service, Canberra, Australia, pp. 43–48.Google Scholar
  72. 72.
    Fligiel, S. E. G., Venkat, H., Gong, H., Jr., and Tashkin, D. P. (1988),J. Psychoactive Drugs 20, 33–42.PubMedGoogle Scholar
  73. 73.
    Henderson, R. L., Tennant, F. S., and Guerry, R. (1972),Arch. Otolaryngol. 95, 248–251.PubMedGoogle Scholar
  74. 74.
    Tennant, F. S., Jr. (1980),Subst. Alcohol Actions Misuse 1, 93–100.PubMedGoogle Scholar
  75. 75.
    Anderson, A. E., Jr. and Foraker, A. G. (1961),Arch. Pathol. 72, 520–534.PubMedGoogle Scholar
  76. 76.
    Cosio, M., Ghezzo, H., Hogg, J. C., Corbin, R., Loveland, M., Dosman, J., and Macklem, P. T. (1978),N. Engl. J. Med. 298, 1277–1281.PubMedCrossRefGoogle Scholar
  77. 77.
    Niewoehner, D. E., Kleinerman, J., and Rice, D. B. (1974),N. Engl. J. Med. 291, 755–758.PubMedCrossRefGoogle Scholar
  78. 78.
    Barbers, R. G., Gong, H., Jr., Tashkin, D. P., Oishi, J., and Wallace, J. M. (1987),Am. Rev. Respir. Dis. 135, 1271–1275.PubMedGoogle Scholar
  79. 79.
    Barbers, R. G., Evans, M. J., Gong, H., Jr., and Tashkin, D. P. (1991),Am. Rev. Respir. Dis. 143, 1092–1095.PubMedGoogle Scholar
  80. 80.
    Wallace, J. M., Oishi, J. S., Barbers, R. G., Simmons, M. S., and Tashkin, D. P. (1994),Chest 105, 847–852.PubMedGoogle Scholar
  81. 81.
    Tashkin, D. P., Coulson, A. H., Clark, V. A., Simmons, M., Bourque, L. B., Duann, S., Spivey, G. H., and Gong, H., Jr. (1987),Am. Rev. Respir. Dis. 135, 209–216.PubMedGoogle Scholar
  82. 82.
    Simmons, M. S. and Tashkin, D. P. (1995),Life Sci. 56, 2185–2191.PubMedCrossRefGoogle Scholar
  83. 83.
    Tashkin, D. P., Khalsa, M. E., Gorelick, D., Chang, P., Simmons, M. S., Coulson, A.H., and Gong, H., Jr. (1992),Am. Rev. Respir. Dis. 145, 92–100.PubMedGoogle Scholar
  84. 84.
    Tashkin, D. P., Simmons, M. S., Chang, P. Liu, H., and Coulson, A. H. (1993).Am. Rev. Respir. Dis. 147, 97–103.PubMedGoogle Scholar
  85. 85.
    Tashkin, D. P., Fligiel, S., Wu, T. C., Gong, H., Jr., Barbers, R. G., Coulson, A. H., Simmons, M. S., and Beals, T. F. (1990),NIDA Res. Monogr. 99, 63–87.PubMedGoogle Scholar
  86. 86.
    Polen, M. R., Sidney, S., Tekawa, I. S., Sadler, M., and Friedman, G. D. (1993),West. J. Med. 158, 596–601.PubMedGoogle Scholar
  87. 87.
    Cottrell, J. C., Sohn, S. S., and Vogel, W. H. (1973),Arch. Environ. Health 26, 277, 278.PubMedGoogle Scholar
  88. 88.
    Leuchtenberger, C., Leuchtenberger, R., Ritter, U., and Inui, N. (1973),Nature (Lond.)242, 403, 404CrossRefGoogle Scholar
  89. 89.
    Sherman, M. P., Aeberhard, E. E., Wong, V. Z., Simmons, M. S., Roth, M. D., and Tashkin, D. P. (1995),Life Sci. 56, 2201–2207.PubMedCrossRefGoogle Scholar
  90. 90.
    Leuchtenberger, C. and Leuchtenberger, R. (1976), inThe Pharmacology of Marijuana, Braude, M. C., and Szara, S., eds., Raven, New York, pp. 595–612.Google Scholar
  91. 91.
    Lee, M., Novotny, M., and Bartle, K. (1976),Anal. Chem. 48, 405–416.PubMedCrossRefGoogle Scholar
  92. 92.
    Tashkin, D. P. (1990),West. J. Med. 152, 525–530.PubMedGoogle Scholar
  93. 93.
    Tashkin, D. P. (1993),West. J. Med. 158, 635–637.PubMedGoogle Scholar
  94. 94.
    Busch, F. W., Seid, D. A., and Wei, E. T. (1979),Cancer Lett. 6, 319–324.PubMedCrossRefGoogle Scholar
  95. 95.
    Wehner, F. C., Van Rensburg, S. J., and Thiel, P. G. (1980),Mutat. Res. 77, 135–142.PubMedCrossRefGoogle Scholar
  96. 96.
    Sparacino, C. M., Hyldburg, P. A., and Hughes, T. J. (1990),NIDA Res. Monogr. 99, 121–140.PubMedGoogle Scholar
  97. 97.
    Donald, P. J. (1986),Otolaryngol. Head Neck Surg. 94, 517–521.PubMedGoogle Scholar
  98. 98.
    Taylor, F. M., III (1988),South. Med. J. 81, 1213–1216.PubMedGoogle Scholar
  99. 99.
    Caplan, G. A. and Brigham, B. A. (1990),Cancer 66, 1005, 1006.PubMedCrossRefGoogle Scholar
  100. 100.
    Donald, P. J. (1991), inAdvances in the Biosciences: Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates, vol. 80, Nahas, G. G. and Latour, C., eds., Oxford, Pergamon, pp. 39–54.Google Scholar
  101. 101.
    Endicott, J., Skipper, P., and Hernandez, L. (1993),Adv. Exp. Med. Biol. 335, 107–113.PubMedGoogle Scholar
  102. 102.
    Donald, P. J., Hayes, H. R., and Dhaliwal, R. (1980),Otolaryngol. Head Neck Surg. 88, 738–744.PubMedGoogle Scholar
  103. 103.
    Ferguson, R. P., Hasson, J., and Walker, S. (1989), (Letter)JAMA 261, 41, 42.PubMedCrossRefGoogle Scholar
  104. 104.
    Friedman, H., Klein, T. W., Newton, C., and Daaka, Y. (1995),Adv. Exp. Med. Biol. 373, 103–113.PubMedGoogle Scholar
  105. 105.
    Schatz, A. R., Kessler, F. K., and Kaminski, N. E. (1992),Life Sci. 51, PL25-PL30.PubMedCrossRefGoogle Scholar
  106. 106.
    Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., and Kessler, F. K. (1994),Biochem. Pharmacol. 48, 1899–1908.PubMedCrossRefGoogle Scholar
  107. 107.
    Daaka, Y., Klein, T. W., and Friedman, H. (1995),Adv. Exp. Med. Biol. 373, 91–96.PubMedGoogle Scholar
  108. 108.
    Huber, G. L., Shea, J. W., Hinds, W. C., Pochay, V. E., Weker, R. T., First, M. W., and Sornberger, G. C. (1979),Bull. Eur. Physiopathol. Respir. 15, 491–503.Google Scholar
  109. 109.
    Huber, G. L., Simmons, G. A., McCarthy, C. R., Cutting, M. B., Laguarda, R., and Pereira, W. (1975),Chest 68, 769–773.PubMedGoogle Scholar
  110. 110.
    Tang, J. L., Lancz, G., and Specter, S. (1993),Int. J. Immunopharmacol. 15, 665–672.PubMedCrossRefGoogle Scholar
  111. 111.
    Guarisco, J. L., Cheney, M. L., LeJeune, F. E., and Reed, H. T. (1988),Laryngoscope 98, 1309–1312.PubMedGoogle Scholar
  112. 112.
    Juel-Jensen, B. E. (1972),Br. Med. J. 4, 296.PubMedGoogle Scholar
  113. 113.
    Bradley, S. G., Munson, A. E., Dewey, W. L., and Harris, L. S. (1977),Infect. Immun. 17, 325–329.PubMedGoogle Scholar
  114. 114.
    Morahan, P. S., Klykken, P. C., Smith, S. H., Harris, L. S., and Munson, A. E. (1979),Infect. Immun. 23, 670–674.PubMedGoogle Scholar
  115. 115.
    Huber, G. L., Pochay, V. E., Pereira, W., Shea, J. W., Hinds, W. C., First, M. W., and Sornberger, G. C. (1980),Chest 77, 403–410.PubMedGoogle Scholar
  116. 116.
    Nahas, G. G., Suciu-Foca, N., Armand, J. P., and Morishima, A. (1974),Science 183, 419, 420.PubMedCrossRefGoogle Scholar
  117. 117.
    Klein, T. W., Newton, C. A., Widen, R., and Friedman, H. (1985),J. Immunopharmacol. 7, 451–466.PubMedGoogle Scholar
  118. 118.
    Gupta, S., Grieco, M. H., and Cushman, P., Jr. (1974),N. Engl. J. Med. 291, 874–877.PubMedCrossRefGoogle Scholar
  119. 119.
    Cushman, P. and Khurana, R. (1976),Clin. Pharmacol. Ther. 19, 310–317.PubMedGoogle Scholar
  120. 120.
    Schwarz, H., Blanco, F. J., and Lotz, M. (1994),J. Neuroimmunol. 55, 107–115.PubMedCrossRefGoogle Scholar
  121. 121.
    Diaz, S., Specter, S., Vanderhoek, J. Y., and Coffey, R. G. (1994),J. Pharmacol. Exp. Ther. 268, 1289–1296.PubMedGoogle Scholar
  122. 122.
    Pross, S. H., Klein, T. W., Newton, C. A., Smith, J., Widen, R., and Friedman, H., (1990),Int. J. Immunopharmacol. 12, 539–544.PubMedCrossRefGoogle Scholar
  123. 123.
    Fischer-Stenger, K., Updegrove, A. W., and Cabral, G. A. (1992),Proc. Soc. Exp. Biol. Med. 200, 422–430.PubMedGoogle Scholar
  124. 124.
    Schatz, A. R., Koh, W. S., and Kaminski, N. E. (1993),Immunopharmacology 26, 129–137.PubMedCrossRefGoogle Scholar
  125. 125.
    Condie, R., Herring, A., Koh, W. S., Lee, M., and Kaminski, N. E. (1996),J. Biol. Chem. 271, 13,175–13,183.Google Scholar
  126. 126.
    Newton, C. A., Klein, T. W., and Friedman, H. (1994),Infect. Immun. 62, 4015–4020.PubMedGoogle Scholar
  127. 127.
    Specter, S., Lancz, G., Westrich, G., and Friedman, H. (1991),Int. J. Immunopharmacol. 13, 411–417.PubMedCrossRefGoogle Scholar
  128. 128.
    Nakano, Y., Pross, S. H., and Friedman, H. (1992),Proc. Soc. Exp. Biol. Med. 201, 165–168.PubMedGoogle Scholar
  129. 129.
    Nakano, Y., Pross, S., and Friedman, H. (1993),Life Sci. 52, 41–51.PubMedCrossRefGoogle Scholar
  130. 130.
    Trisler, K. and Specter, S. (1994),Int. J. Immunopharmacol. 16, 593–603.PubMedCrossRefGoogle Scholar
  131. 131.
    Kawakami, Y., Klein, T. W., Newton, C. A., Djeu, J. Y., Specter, S., and Friedman, H. (1988),Int. J. Immunopharmacol. 10, 485–488.PubMedCrossRefGoogle Scholar
  132. 132.
    Kawakami, Y., Klein, T. W., Newton, C. A., McCarthy, C. A., Djeu, J. Y., Dennert, G., Specter, S., and Friedman, H. (1988),Proc. Soc. Exp. Biol. Med. 187, 355–359PubMedGoogle Scholar
  133. 133.
    Zhu, W., Igarashi, T., Qi, Z. T., Newton, C., Widen, R. E., Friedman, H., and Klein, T. W. (1993),Int. J. Immunopharmacol. 15, 401–408.PubMedCrossRefGoogle Scholar
  134. 134.
    Zhu, W., Igarashi, T., Friedman, H., and Klein, T. W. (1995),J. Pharmacol Exp. Ther. 274, 1001–1007.PubMedGoogle Scholar
  135. 135.
    Tang, J. L., Lancz, G., Specter, S., and Bullock, H. (1992),Int. J. Immunopharmacol. 14, 253–262.PubMedCrossRefGoogle Scholar
  136. 136.
    Arata, S., Newton, C., Klein, T., and Friedman, H. (1992),Proc. Soc. Exp. Biol. Med. 199, 65–67.PubMedGoogle Scholar
  137. 137.
    Sherman, M. P., Campbell, L. A., Gong, H., Jr., Roth, M. D., and Tashkin, D. P. (1991),Am. Rev. Respir. Dis. 144, 1351–1356.PubMedGoogle Scholar
  138. 138.
    Cabral, G. A. and Vasquez, R. (1992),Proc. Soc. Exp. Biol. Med. 199, 255–263.PubMedGoogle Scholar
  139. 139.
    Cabral, G. A. and Fischer-Stenger, K. (1994),Life Sci. 54, 1831–1844.PubMedCrossRefGoogle Scholar
  140. 140.
    Burnette-Curley, D., Marciano-Cabral, F., Fischer-Stenger, K., and Cabral, G. A. (1993),Int. J. Immunopharmacol. 15, 371–382.PubMedGoogle Scholar
  141. 141.
    Cabral, G. A., Stinnett, A. L., Bailey, J., Ali, S. F., Paule, M. G., Scallet, A. C., and Slikker, W., Jr., (1991),Pharmacol. Biochem. Behav. 40, 643–649.PubMedCrossRefGoogle Scholar
  142. 142.
    Zheng, Z. M. and Specter, S. (1994),Biochem. Pharmacol. 47, 2243–2252.PubMedCrossRefGoogle Scholar
  143. 143.
    Sherman, M. P., Roth, M. D., Gong, H., Jr., and Tashkin, D. P. (1991),Pharmacol. Biochem. Behav. 40, 663–669.PubMedCrossRefGoogle Scholar
  144. 144.
    McCoy, K. L., Gainey, D., and Cabral, G. A. (1995),J. Pharmacol. Exp. Ther. 273, 1216–1223.PubMedGoogle Scholar
  145. 145.
    Shivers, S. C., Newton, C., Friedman, H., and Klein, T. W. (1994),Life Sci. 54, 1281–1289.PubMedCrossRefGoogle Scholar
  146. 146.
    Zhu, W., Newton, C., Daaka, Y., Friedman, H., and Klein, T. W. (1994),J. Pharmacol. Exp. Ther. 270, 1334–1339.PubMedGoogle Scholar
  147. 147.
    Zheng, Z. M., Specter, S., and Friedman, H. (1992),Int. J. Immunopharmacol. 14, 1445–1452.PubMedCrossRefGoogle Scholar
  148. 148.
    Fischer-Stenger, K., Dove Pettit, D. A., and Cabral, G. A. (1993),J. Pharmacol. Exp. Ther. 267, 1558–1565.PubMedGoogle Scholar
  149. 149.
    Kusher, D. I., Dawson, L. O., Taylor, A. C., and Djeu, J. Y. (1994),Cell. Immunol. 154, 99–108.PubMedCrossRefGoogle Scholar
  150. 150.
    Specter, S. C., Klein, T. W., Newton, C., Mondragon, M., Widen, R., and Friedman, H. (1986),Int. J. Immunopharmacol. 8, 741–745.PubMedCrossRefGoogle Scholar
  151. 151.
    Audette, C. and Burstein, S. (1990),Life Sci. 47, 753–759.PubMedCrossRefGoogle Scholar
  152. 152.
    Klein, T. W., Newton, C., Widen, R., and Friedman, H. (1993),J. Pharmacol. Exp. Ther. 267, 635–640.PubMedGoogle Scholar
  153. 153.
    Miller, W. E., Spiekerman, R. E., and Hepper, N. G. (1972),Chest 62, 233, 234.PubMedGoogle Scholar
  154. 154.
    Mattox, K. L. (1976),JACEP 5, 26–28.PubMedGoogle Scholar
  155. 155.
    Gil, E., Chen, B., Kleerup, E., Webber, M., and Tashkin, D. P. (1995),Life Sci. 56, 2193–2199.PubMedCrossRefGoogle Scholar
  156. 156.
    Jusko, W. J., Schentag, J. J., Clark, J. H., Gardner, M., and Yurchak, A. M. (1978),Clin. Pharmacol. Ther. 24, 405–410.PubMedGoogle Scholar
  157. 157.
    Ghosh, S. K. and Poddar, M. K. (1992),Biochem. Pharmacol. 44, 2021–2027.PubMedCrossRefGoogle Scholar
  158. 158.
    Kagen, S. L. (1981) (letter),N. Engl. J. Med. 304, 483, 484.PubMedGoogle Scholar
  159. 159.
    Hamadeh, R., Ardehali, A., Locksley, R. M., and York, M. K. (1988),Chest 94, 432, 433.PubMedGoogle Scholar
  160. 160.
    Chusid, M. J., Gelfand, J. A., Nutter, C., and Fauci, A. S. (1975) (Letter),Ann. Intern. Med. 82, 682, 683.PubMedGoogle Scholar
  161. 161.
    Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H., and Stevens, D. A. (1991),N. Engl. J. Med. 324, 654–662.PubMedCrossRefGoogle Scholar
  162. 162.
    Schwartz, I. S. (1985) (letter),Am. J. Clin. Pathol. 84, 256.PubMedGoogle Scholar
  163. 163.
    Llamas, R., Hart, D. R., and Schneider, N. S. (1978),Chest 73, 871, 872.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 1997

Authors and Affiliations

  • Brent E. Van Hoozen
    • 1
  • Carroll E. Cross
    • 1
  1. 1.Division of Pulmonary and Critical Care MedicineUniversity of California at DavisSacramento

Personalised recommendations